COVID-19
ESMO21: Latest Clinical Studies Answer Central Questions in the Treatment of Leading Cancers
2021-09-22
Japan’s Nippon Foundation Injects $210M into Osaka University’s 10-Year Infectious Diseases Research Plan
2021-09-15
This Australian Biotech is Developing a Nanocellular COVID-19 Vaccine for the Immunocompromised
2021-09-09
Mu COVID Variant Could Potentially Escape Immunity But Delta is Still “Most Concerning”, WHO Says
2021-09-08
China’s Abogen Raises $700M to Fund the First Homegrown mRNA COVID-19 Vaccine to Enter Human Trial
2021-08-20